{
    "2015-09-30": [
        "Pfizer Inc. updates FY15 guidance to $2.04-2.10 EPS & revenue guidance to $46.5-47.5 billion.",
        "VLO Valero Energy Corp E.P.S.",
        "$PFE updates 2015 guidance post $HSP: Lowers EPS 9 cents, Raises adj EPS 3 cents, Raises rev $1.5B",
        "Pfizer boosts full-year forecast following Hospira acquisition",
        "Dako to develop companion diagnostic for Pfizer and Merck KGaA's joint cancer candidate"
    ]
}